NFKB1 and gastric adenocarcinoma: The treatment of human gastric adenocarcinoma cell-line (AGS) with quercetin (10 μM) for 72 h inhibited the activation of NF-κB through the reduction of p65 phosphorylation, suggesting that quercetin can hamper NF-κB pathway activation and act as a potential anti-inflammatory agent [163].